Corporate Tech Investors

Moderna Therapeutics

Moderna Therapeutics is a corporate venture capital group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Moderna is pioneering messenger RNA therapeutics, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. This breakthrough platform addresses currently undruggable targets, and offers a superior alternative to existing drug modalities for a wide range of disease conditions.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/2/2022

Transaction History

Our records indicate that Moderna Therapeutics invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Stephane Bancel

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Moderna Therapeutics has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Modern Health | Moinian

Share this article

About Our Corporate VC Strategic Investors Directory

The strategic investor data above is provided by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary